UNSPSC 51452602: Netobimin

This classification denotes an antihelminthic agent with the molecular formula C14H20N4O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U30C54N3MU, chemically known as ethanesulfonic acid, 2-((((methoxycarbonyl)amino)((2-nitro-5-(propylthio)phenyl)imino)methyl)amino)- but generally known as netobimin, which bears US NIH Compound Identifier 71449. European Medicines Agency schedules Netobimin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09212MIG.

UNSPSC 51452602 Netobimin, a Commodity code, covers pharmaceutical products and medical supplies procured by state and local governments, though recent opportunities tagged under this code diverge significantly from the code's nominal scope. The Seminole County, Florida IFB sought naloxone and drug deactivation systems for community health initiatives; the City of Tampa's IFB targeted medical and first aid supplies for the Fire Department Rescue Division, including respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, and other emergency response consumables; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP sought generic multi-source pharmaceuticals and over-the-counter products for distribution across participating state and local government facilities. The Texas Health and Human Services Commission's RFI, by contrast, focused on market intelligence for a direct-to-manufacturer prescription program rather than a discrete product category. Issuing bodies include county health departments, municipal fire and rescue services, state cooperative purchasing alliances, and state health agencies. Procurement vehicles include competitive sealed bids (IFB) and formal requests for proposal (RFP), with response deadlines ranging from immediate to several weeks post-posting.

Geographic activity spans Florida, Texas, Minnesota, and Oregon through MMCAP's multi-state purchasing authority. Seminole County's naloxone procurement (IFB 60459723LAS, response due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The City of Tampa's medical supplies bid (26P00145, response due March 13, 2026) encompassed 169 line items with an estimated contract value of $700,000 and designated the opportunity as a sheltered market exclusive to certified Small Local Business Enterprises with a 5 percent bid discount. The MMCAP RFP (S1070000015802, response due March 26, 2026) required vendors to supply products through three authorized wholesalers and anticipated contract effectiveness on July 1, 2026, with evaluations weighted 75 percent on price competitiveness and 25 percent combined on pricing structure compliance, EDI capability, and administrative fee acceptance.